Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Julio Vladimir Cruz"'
Autor:
Rojelio Mejia, Barton Slatko, Cristina Almazan, Ruben Cimino, Alejandro Krolewiecki, Natalia Montellano Duran, Jacob Edwin Valera Aspetty, Paola Andrea Vargas, Chiara Cássia Oliveira Amorim, Stefan Michael Geiger, Ricardo Toshio Fujiwara, Juan David Ramirez, Luz Marina Llangarí-Arizo, Irene Guadalupe, Liliana E. Villanueva-Lizama, Julio Vladimir Cruz-Chan, María Leticia Ojeda, Eva Mereles Aranda, Sandra Ocampos Benedetti, Maritza Dalí Camones Rivera, Eddyson Montalvo Sabino, Carlos Pineda, Eric J. Wetzel, Philip J. Cooper
Publikováno v:
Tropical Medicine and Infectious Disease, Vol 9, Iss 10, p 226 (2024)
We discuss the potential usefulness of molecular testing of soil, dust, and water samples to detect medically important parasites, and where such testing could be used to supplement stool sampling in humans. A wide variety of parasites including prot
Externí odkaz:
https://doaj.org/article/0efee8821e6540faa58c104aa2efae8a
Autor:
Kathryn M. Jones, Elise N. Mangin, Corey L. Reynolds, Liliana E. Villanueva, Julio Vladimir Cruz, Leroy Versteeg, Brian Keegan, April Kendricks, Jeroen Pollet, Fabian Gusovsky, Maria Elena Bottazzi, Peter J. Hotez
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 13 (2023)
IntroductionChagas disease, caused by chronic infection with the protozoan parasite Trypanosoma cruzi, affects 6-7 million people worldwide. The major clinical manifestation of Chagas disease is chronic Chagasic cardiomyopathy (CCC), which encompasse
Externí odkaz:
https://doaj.org/article/14e07b78bb6a483e8f272051a2aa934e
Autor:
Bárbara Carolina Arias-Argáez, Victor Manuel Dzul-Huchim, Ana Paulina Haro-Álvarez, Miguel Enrique Rosado-Vallado, Liliana Villanueva-Lizama, Julio Vladimir Cruz-Chan, Eric Dumonteil
Publikováno v:
PLoS ONE, Vol 18, Iss 10, p e0292520 (2023)
Chagas disease by Trypanosoma cruzi (T. cruzi) infection is a leading cause of myocarditis worldwide. Chagas cardiomyopathy is presented with a wide variety of conduction abnormalities including arrhythmias, first- and second-degree atrioventricular
Externí odkaz:
https://doaj.org/article/2bee7d73319d4555b2c2efeb87928807
Autor:
Victor Manuel Dzul-Huchim, Maria Jesus Ramirez-Sierra, Pedro Pablo Martinez-Vega, Miguel Enrique Rosado-Vallado, Victor Ermilo Arana-Argaez, Jaime Ortega-Lopez, Fabian Gusovsky, Eric Dumonteil, Julio Vladimir Cruz-Chan, Peter Hotez, María Elena Bottazzi, Liliana Estefania Villanueva-Lizama
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 16, Iss 9, p e0010258 (2022)
BackgroundChagas disease (CD) is caused by Trypanosoma cruzi and affects 6-7 million people worldwide. Approximately 30% of chronic patients develop chronic chagasic cardiomyopathy (CCC) after decades. Benznidazole (BNZ), one of the first-line chemot
Externí odkaz:
https://doaj.org/article/374146e448344e15b0bf078cd3e7e089
Autor:
Julio Vladimir Cruz-Chan, Amarú del Carmen Aguilar-Cetina, Liliana Estefanía Villanueva-Lizama, Pedro Pablo Martínez-Vega, Maria Jesús Ramírez-Sierra, Miguel Enrique Rosado-Vallado, José Leonardo Guillermo-Cordero, Eric Dumonteil
Publikováno v:
Parasites & Vectors, Vol 7, Iss 1, Pp 1-9 (2014)
Abstract Background Cutaneous leishmaniasis is a tropical disease affecting over one million patients annually and Leishmania (L.) mexicana is one of the major etiological agents in the Americas. Here we established the first experimental infection o
Externí odkaz:
https://doaj.org/article/36be322b4a9b4c8d9aee8d80364a000a
Autor:
Cristina González-López, Wen-Hsiang Chen, Andrea Alfaro-Chacón, Liliana E. Villanueva-Lizama, Miguel Rosado-Vallado, Maria Jesús Ramirez-Sierra, Christian F. Teh-Poot, Jeroen Pollet, Oluwatoyin Asojo, Kathryn M. Jones, Peter J. Hotez, Maria Elena Bottazzi, Julio Vladimir Cruz-Chan
Publikováno v:
Vaccine, 40(45), 6445-6449. Elsevier
About 6.5 million people worldwide are afflicted by Chagas disease, which is caused by the protozoan parasite Trypanosoma cruzi. The development of a therapeutic vaccine to prevent the progression of Chagasic cardiomyopathy has been proposed as an al
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44adf1794cfce6196279d909791d680
https://pure.eur.nl/en/publications/07446616-4e7d-4c26-84c6-22d07d88d2b0
https://pure.eur.nl/en/publications/07446616-4e7d-4c26-84c6-22d07d88d2b0
Autor:
Christian Florian Teh-Poot, Victor Manuel Dzul-Huchim, Jonathan M. Mercado, Liliana Estefanía Villanueva-Lizama, Maria Elena Bottazzi, Kathryn M. Jones, Francis T.F. Tsai, Julio Vladimir Cruz-Chan
Publikováno v:
Experimental Parasitology. 249:108519
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::95bc4a6e4dc10135cd55f5e8d77eef0c
https://doi.org/10.1016/j.exppara.2023.108519
https://doi.org/10.1016/j.exppara.2023.108519
Autor:
Victor Manuel Dzul-Huchim, Maria Jesus Ramirez-Sierra, Pedro Pablo Martinez-Vega, Miguel Enrique Rosado-Vallado, Victor Ermilo Arana-Argaez, Jaime Ortega-Lopez, Fabian Gusovsky, Eric Dumonteil, Julio Vladimir Cruz-Chan, Peter Hotez, María Elena Bottazzi, Liliana Estefania Villanueva-Lizama
BackgroundChagas disease (CD) is caused by Trypanosoma cruzi and affects 6-7 million people worldwide. Approximately 30% of chronic patients develop chronic chagasic cardiomyopathy (CCC) after decades. Benznidazole (BNZ), one of the first-line chemot
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::459b59eeb3325614e2dba7fee57b62f4
https://doi.org/10.1101/2022.02.16.480638
https://doi.org/10.1101/2022.02.16.480638
Autor:
Julio Vladimir Cruz-Chan, Fabian Gusovsky, Liliana Estefanía Villanueva-Lizama, Jeroen Pollet, Kathryn M. Jones, Kristyn Hoffman, Maria Elena Bottazzi, April Kendricks, Leroy Versteeg, Brian Keegan, Peter J. Hotez, Christian Teh-Poot
Publikováno v:
Parasite immunologyREFERENCES. 42(10)
E6020 is a synthetic agonist of Toll-like receptor-4 (TLR4). The purpose of this study was to evaluate the effect of different doses of E6020-SE on Trypanosoma cruzi-specific immune responses and its ability to confer protection against acute lethal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bf4f64a635ca40c568c0f39ceb533c42
https://pubmed.ncbi.nlm.nih.gov/32592180
https://pubmed.ncbi.nlm.nih.gov/32592180
Autor:
Brian Keegan, Jeroen Pollet, Leroy Versteeg, Julio Vladimir Cruz-Chan, Peter J. Hotez, Maria Elena Bottazzi, Kathryn M. Jones, Fabian Gusovsky, Ashish Damania, April Kendricks
Publikováno v:
Infection and immunity. 86(4)
Chagas disease affects 6 to 7 million people worldwide, resulting in significant disease burdens and health care costs in countries of endemicity. Chemotherapeutic treatment is restricted to two parasiticidal drugs, benznidazole and nifurtimox. Both
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4fcb423f25be452a87df5725b7a24cd
https://pubmed.ncbi.nlm.nih.gov/29311242
https://pubmed.ncbi.nlm.nih.gov/29311242